BCR ABL P210 CML Whole Blood Treatment Monitoring

Message

The Expert BCR-ABL Ultra test is an in vitro diagnostic test for the quantitation of BCR-ABL1 mRNA transcripts in peripheral blood specimens of diagnosed positive Chronic Myeloid Leukemia (CML) patients expressing BCR-ABL1 fusion transcripts type e13a2 and/or e14a2. The test is intended to measure BCR-ABL1 to ABL1 percent ratios on the International Scale (IS) and also expressed as a log molecular reduction (MR Value) from a baseline of 100% (IS) in positive CML patients during monitoring of treatment with Tyrosine Kinase Inhibitors (TKIs).

This test is not intended for the diagnosis of CML.

Test Code

BCRAB

Preferred Specimen

PINK EDTA

Minimum Volume

4 mL

Report Available

Set up M-Saturday
Batch testing 1x per day

Reference Range

Negative

Result Options:

Positive (Reported with %IS and Molecular Response values)
Positive (Above upper Limit)
Positive (Below detection limit, >MR4.52/<0.0030%IS)
Negative (Sufficient ABL Transcript)

Performing Laboratory
CRMC Laboratory

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.